SCHEMBL5445833

SCHEMBL5445833

CC(C)C(F)(F)c1ccc(OCC(=O)NCc2ccc(NS(C)(=O)=O)c(F)c2)cc1

nearest known ligand 0.60

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 4/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5274372 0.90 TRPV1 (0.56) TRPV1
SCHEMBL4680698 0.88 TRPV1 (0.67) TRPV1
SCHEMBL4640600 0.88 TRPV1 (0.56) TRPV1
SCHEMBL5277826 0.86 TRPV1 (0.53) TRPV1
SCHEMBL5272553 0.86 RAB9A (0.52) TRPV1
SCHEMBL4640594 0.86 TRPV1 (0.56) TRPV1
SCHEMBL14384563 0.85 HPGD (0.56)
SCHEMBL5278547 0.84 TRPV1 (0.52) TRPV1
SCHEMBL5274996 0.84 TAOK1 (0.53)
SCHEMBL5279144 0.84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007120012-A1 NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST; AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AMOREPACIFIC CORPORATION (KR) 2007-10-25 WO disclosed
WO-2007120012-A1 NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST; AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AMOREPACIFIC CORPORATION (KR) 2007-10-25 WO disclosed